WO2008107569A3 - Complexes d'inclusion de cysteine, leur preparation et les compositions les contenant - Google Patents

Complexes d'inclusion de cysteine, leur preparation et les compositions les contenant Download PDF

Info

Publication number
WO2008107569A3
WO2008107569A3 PCT/FR2008/000126 FR2008000126W WO2008107569A3 WO 2008107569 A3 WO2008107569 A3 WO 2008107569A3 FR 2008000126 W FR2008000126 W FR 2008000126W WO 2008107569 A3 WO2008107569 A3 WO 2008107569A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions containing
inclusion complexes
containing same
cysteine
cysteine inclusion
Prior art date
Application number
PCT/FR2008/000126
Other languages
English (en)
Other versions
WO2008107569A2 (fr
Inventor
Mohamed Skiba
Frederic Bounoure
Malika Lahiani-Skiba
Pierre Dechelotte
Original Assignee
Aliscience
In Cyclo
Mohamed Skiba
Frederic Bounoure
Malika Lahiani-Skiba
Pierre Dechelotte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aliscience, In Cyclo, Mohamed Skiba, Frederic Bounoure, Malika Lahiani-Skiba, Pierre Dechelotte filed Critical Aliscience
Publication of WO2008107569A2 publication Critical patent/WO2008107569A2/fr
Publication of WO2008107569A3 publication Critical patent/WO2008107569A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Complexe d'inclusion ou mélange de complexes d'inclusion à base d'un ou plusieurs acides aminés saufrés, leurs dérivés ou sels et d'au moins une cyclodextrine ou dérivé (s) de celle (s) -ci.
PCT/FR2008/000126 2007-02-01 2008-02-01 Complexes d'inclusion de cysteine, leur preparation et les compositions les contenant WO2008107569A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0753010A FR2912061A1 (fr) 2007-02-01 2007-02-01 Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant
FR0753010 2007-02-01

Publications (2)

Publication Number Publication Date
WO2008107569A2 WO2008107569A2 (fr) 2008-09-12
WO2008107569A3 true WO2008107569A3 (fr) 2008-11-06

Family

ID=38445818

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2008/000126 WO2008107569A2 (fr) 2007-02-01 2008-02-01 Complexes d'inclusion de cysteine, leur preparation et les compositions les contenant

Country Status (2)

Country Link
FR (1) FR2912061A1 (fr)
WO (1) WO2008107569A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115191538A (zh) * 2022-07-14 2022-10-18 河北工业职业技术学院 氨基酸饮料及其制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072868A1 (fr) * 1981-02-28 1983-03-02 Santen Pharmaceutical Co., Ltd. Composes clathrates de cyclodextrine de composes contenant du soufre
FR2563430A1 (fr) * 1982-11-08 1985-10-31 Shiseido Co Ltd Lotion d'ondulation pour permanente a froid
EP0647451A1 (fr) * 1993-10-08 1995-04-12 South African Druggist Limited Complexe d'inclusion de la bêta-cyclodextrine avec le diclofénac
FR2716625A1 (fr) * 1994-02-25 1995-09-01 Gouchet Franck Arno Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non.
WO1997019703A2 (fr) * 1995-11-29 1997-06-05 Hexal Ag Complexes de thyroxine/cyclodextrine et compositions pharmaceutiques contenant ceux-ci
EP0839528A1 (fr) * 1996-10-29 1998-05-06 Staroil Limited Compositions solubles dans la bouche contenant de la N-acetyl-cysteine et de la cyclodextrine
WO2004019989A1 (fr) * 2002-08-27 2004-03-11 Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Compose d'inclusion a base de nateglinide
WO2005056607A1 (fr) * 2003-12-12 2005-06-23 Belupo-Lijekovi I Kozmetika D.D. Procede de production de complexes d'inclusion de valsartan et de $g(b)-cyclodextrine

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072868A1 (fr) * 1981-02-28 1983-03-02 Santen Pharmaceutical Co., Ltd. Composes clathrates de cyclodextrine de composes contenant du soufre
FR2563430A1 (fr) * 1982-11-08 1985-10-31 Shiseido Co Ltd Lotion d'ondulation pour permanente a froid
EP0647451A1 (fr) * 1993-10-08 1995-04-12 South African Druggist Limited Complexe d'inclusion de la bêta-cyclodextrine avec le diclofénac
FR2716625A1 (fr) * 1994-02-25 1995-09-01 Gouchet Franck Arno Préparation et utilisation de formes pharmaceutiques et cosmétiques contenant des composés d'inclusion avec les cyclodextrines de cystéamine, sels de cystéamine, ou dérivés de la cystéamine, sous forme de sel ou non.
WO1997019703A2 (fr) * 1995-11-29 1997-06-05 Hexal Ag Complexes de thyroxine/cyclodextrine et compositions pharmaceutiques contenant ceux-ci
EP0839528A1 (fr) * 1996-10-29 1998-05-06 Staroil Limited Compositions solubles dans la bouche contenant de la N-acetyl-cysteine et de la cyclodextrine
WO2004019989A1 (fr) * 2002-08-27 2004-03-11 Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Compose d'inclusion a base de nateglinide
WO2005056607A1 (fr) * 2003-12-12 2005-06-23 Belupo-Lijekovi I Kozmetika D.D. Procede de production de complexes d'inclusion de valsartan et de $g(b)-cyclodextrine

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200423, Derwent World Patents Index; AN 2004-248194, XP002449706 *
LANTZ ET AL: "Estimation of association constants between oral malodor components and various native and derivatized cyclodextrins", ANALYTICA CHIMICA ACTA, ELSEVIER, AMSTERDAM, NL, vol. 557, no. 1-2, 31 January 2006 (2006-01-31), pages 184 - 190, XP005249489, ISSN: 0003-2670 *
LIU, YU ET AL: "Molecular recognition study of a supramolecular system. XI. Chiral recognition of aliphatic amino acids by natural and modified .alpha.-cyclodextrins in acidic aqueous solution", BIOORGANIC CHEMISTRY , 25(3), 155-162 CODEN: BOCMBM; ISSN: 0045-2068, 1997, XP002449545 *
MIERTUS S ET AL: "Modeling of .beta.-cyclodextrin with L-.alpha.-amino acids residues", JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, KLUWER, DORDRECHT, NL, vol. 34, no. 1, 1999, pages 69 - 84, XP008083146, ISSN: 1388-3127 *
SZEJTLI ET AL: "Elimination of bitter, disgusting tastes of drugs and foods by cyclodextrins", EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, MEDPHARM SCIENTIFIC PUBL., STUTTGART, DE, vol. 61, no. 3, October 2005 (2005-10-01), pages 115 - 125, XP005255259, ISSN: 0939-6411 *
XIA B Y ET AL: "Chiral recognition study for the inclusion complexes of amino acids with .alpha.-cyclodextrin using a fast annealing evolutionary algorithm", JOURNAL OF MOLECULAR STRUCTURE (THEOCHEM), ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM, NL, vol. 546, 2001, pages 33 - 38, XP008083147, ISSN: 0166-1280 *

Also Published As

Publication number Publication date
WO2008107569A2 (fr) 2008-09-12
FR2912061A1 (fr) 2008-08-08

Similar Documents

Publication Publication Date Title
WO2008137148A3 (fr) Procédés et compositions permettant le traitement de l'hypertension pulmonaire
MY148634A (en) Pyridazinone derivatives
WO2007075901A3 (fr) Promedicaments de modulateurs de transporteurs abc
WO2007106436A3 (fr) Composes et compositions photoactifs et utilisations derivees
WO2008062376A3 (fr) Procédé de fabrication de dérivés de 2-imino-thiazolidino-4-one
WO2008049116A3 (fr) Indoles substitués
WO2006100082A3 (fr) Derives d'oxindole substitues, medicaments contenant ces derives et leur utilisation
WO2007038571A3 (fr) Antagonistes de la prolyl-hydroxylase
WO2007136592A3 (fr) Compositions à base de quinolones substituées et leurs utilisations
CY1114095T1 (el) Μυκητοκτονες συνθεσεις
WO2007062399A3 (fr) Compose cytotoxique speficique du ras oncogene et ses procedes d’utilisation
WO2007030361A3 (fr) Composes de benzimidazole thiophene
IL193772A0 (en) 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same
WO2007061923A3 (fr) Activateurs de la glucokinase
EP2261236A3 (fr) Composition destinée a inhiber le proteasome
WO2009042114A3 (fr) Dérivés de phénazine et leurs utilisations
IL196071A0 (en) Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
WO2008009831A3 (fr) Derives de cyclodextrines amphiphiles
WO2009046842A3 (fr) Dérivés de thiazole
WO2007081878A3 (fr) Voies d'indoléamine 2,3-dioxygénase dans la production de lymphocytes t régulateurs
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
WO2009071689A3 (fr) Dérivés d'oxindole substitués par halogène en position 5 et leur utilisation pour traiter des maladies liées à la vasopressine
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2009007535A3 (fr) Derives de 7 -alkynyl-1.8-naphthyrid0nes, leur preparation et leur application en therapeutique
WO2006097617A3 (fr) Nouveaux derives dihydropyrimidines et leur utilisation comme agents anti-cancereux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08761831

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08761831

Country of ref document: EP

Kind code of ref document: A2